Items where Author is " Gecse Krisztina Barbara"

Number of items: 7.

Gönczi Lóránt and Kürti Zsuzsanna and Rutka Mariann and Végh Zsuzsanna and Farkas Klaudia and Lovász Barbara Dorottya and Golovics Petra Anna and Gecse Krisztina Barbara and Szalay Balázs and Molnár Tamás and Lakatos Péter László: Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases.
BMC GASTROENTEROLOGY, 17 (1). Azonosító: 97.-Terjedelem: 7 p.. ISSN 1471-230X (2017)

Bálint Anita and Rutka Mariann and Végh Zsuzsanna and Kürti Zsuzsanna and Gecse Krisztina Barbara and Lakatos László and Szepes Zoltán and Vincze Áron and Bor Renáta and Milassin Ágnes and Fábián Anna and Nagy Ferenc and Lakatos Péter László and Molnár Tamás and Farkas Klaudia: Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort.
EXPERT OPINION ON DRUG SAFETY, 16 (8). pp. 885-890. ISSN 1474-0338 (2017)

Gönczi Lóránt and Gecse Krisztina Barbara and Végh Zsuzsanna and Kürti Zsuzsanna and Rutka Mariann and Farkas Klaudia and Golovics Petra Anna and Lovász Barbara Dorottya and Banai János and Bene László and Gasztonyi Beáta and Kristóf Tünde and Lakatos László and Miheller Pál and Nagy Ferenc: Long-term efficacy, safety, and immunogenicity of biosimilar infliximab after one year in a prospective nationwide cohort.
INFLAMMATORY BOWEL DISEASES, 23 (11). pp. 1908-1915. ISSN 1078-0998 (2017)

Gönczi Lóránt and Végh Zsuzsanna and Golovics Petra Anna and Rutka Mariann and Gecse Krisztina Barbara and Bor Renáta and Farkas Klaudia and Szamosi Tamás and Bene László and Gasztonyi Beáta and Kristóf Tünde and Lakatos László and Miheller Pál and Palatka Károly and Papp Mária: Prediction of short- and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play a more important role?
JOURNAL OF CROHNS & COLITIS, 11 (6). pp. 697-705. ISSN 1873-9946 (2017)

Gecse Krisztina Barbara and Lovász Barbara Dorottya and Farkas Klaudia and Banai János and Bene László and Gasztonyi Beáta and Golovics Petra Anna and Csontos Ágnes Anna and Juhász Márk and Nagy Ferenc and Papp Mária and Szepes Zoltán and Vincze Áron and Szalay Balázs and Molnár Tamás and Lakatos Péter László: Efficacy and safety of the biosimilar infliximab CT-P13 treatment in inflammatory bowel diseases: a prospective; multicentre; nationwide cohort.
JOURNAL OF CROHNS & COLITIS, 10 (2). pp. 133-140. ISSN 1873-9946 (2016)

Farkas Klaudia and Rutka Mariann and Golovics Petra Anna and Végh Zsuzsanna and Lovász Barbara Dorottya and Nyári Tibor András and Gecse Krisztina Barbara and Kolar Martin and Bortlik Martin and Duricovad Dana and Machkova Nadezda and Hruba Veronika and Bálint Anita and Nagy Ferenc and Bor Renáta and Milassin Ágnes and Szepes Zoltán and Palatka Károly and Lakatos Péter László and Lukasd Milan and Molnár Tamás: Efficacy of infliximab biosimilar CT-P13 induction therapy on mucosal healing in ulcerative colitis.
JOURNAL OF CROHNS & COLITIS, 10 (11). pp. 1273-1278. ISSN 1873-9946 (2016)

Kürti Zsuzsanna and Lovász Barbara Dorottya and Gecse Krisztina Barbara and Bálint Anita and Farkas Klaudia and Morocza-Szabó Ágnes and Gyurcsányi András and Kristóf Attila and Végh Zsuzsanna and Gönczi Lóránt and Kiss Lajos Sándor and Golovics Petra Anna and Lakatos László and Molnár Tamás and Lakatos Péter László: Tuberculin skin test and Quantiferon in BCG vaccinated; immunosuppressed patients with moderate-to-severe inflammatory bowel disease.
Journal of Gastrointestinal and Liver Diseases, 24 (4). pp. 467-472. ISSN 1841-8724 (2015)

This list was generated on 2024. június 16. 02:32:09 CEST.